Evaluation and Management of Sudden Hair Loss in a 19-Year-Old Female
This 19-year-old female requires immediate clinical examination to distinguish between alopecia areata (most likely given the acute 5-day onset), telogen effluvium, or less commonly, tinea capitis or trichotillomania, with minimal laboratory testing needed unless the diagnosis is uncertain.
Initial Clinical Assessment
The sudden onset over just 5 days strongly suggests either alopecia areata or an acute process requiring urgent differentiation. Your examination should focus on:
Key Physical Findings to Identify
- Pattern of hair loss: Focal patches versus diffuse thinning
- Exclamation mark hairs: Short broken hairs (2-3mm) with tapered bases at patch margins—pathognomonic for alopecia areata 1
- Scalp appearance: Normal-appearing skin (alopecia areata) versus inflammation/scaling (tinea capitis) 1
- Pull test: Gently pull 40-60 hairs; >6 hairs removed suggests active shedding
- Nail examination: Pitting or trachyonychia (present in 10% of alopecia areata cases and indicates poorer prognosis) 1
- Dermoscopy findings: Yellow dots and dystrophic hairs support alopecia areata 1
Critical Differential Diagnoses for Acute Onset
The 5-day timeframe is crucial. The British Association of Dermatologists guidelines 1 emphasize these key differentials:
- Alopecia areata - Most likely with focal patches, exclamation mark hairs, normal scalp
- Tinea capitis - Look for scalp inflammation (may be subtle), scaling
- Trichotillomania - Incomplete hair loss, firmly anchored broken hairs still in anagen phase
- Telogen effluvium - Usually occurs 2-3 months after a trigger (fever, surgery, stress), not 5 days 2
- Anagen effluvium - Drug-induced, can mimic diffuse alopecia areata 1
Laboratory Testing Strategy
Investigations are unnecessary in most cases of alopecia areata 1. The guidelines are explicit:
- No routine testing if clinical diagnosis is clear (typical patches with exclamation mark hairs)
- Order tests only when diagnosis is uncertain:
- Fungal culture (if tinea capitis suspected)
- Skin biopsy (if diagnosis unclear—single biopsy sectioned both horizontally and vertically is sufficient) 3
- Serology for lupus or syphilis (if clinically indicated)
Routine autoimmune screening is NOT recommended 3, 1. The 2021 ACE consensus specifically states autoimmune screening investigations are not required for all alopecia areata patients. Similarly, routine iron studies are not recommended as evidence doesn't support treatment response to iron replacement 1.
Management Approach
If Alopecia Areata is Diagnosed
Prognosis discussion is essential: With limited patches (<25% scalp involvement), spontaneous remission within 1 year occurs in 34-80% of cases 1. The hair follicles are preserved, and recovery potential remains even in longstanding disease.
Treatment considerations:
- The guidelines emphasize that alopecia areata has no direct impact on general health that justifies hazardous treatments 1
- Many patients experience spontaneous regrowth
- Treatment decisions should balance psychological impact against treatment risks
If Telogen Effluvium is Suspected
This is less likely given the 5-day onset (typically occurs 2-3 months post-trigger) 2, but if suspected:
- Identify and remove the precipitating cause
- Self-limited; resolves in 3-6 months once trigger is addressed 4, 2
- Reassurance is key
Critical Pitfalls to Avoid
- Over-investigating: Don't order extensive autoimmune panels or iron studies routinely 3, 1
- Missing tinea capitis: Examine carefully for subtle scalp inflammation—this requires antifungal treatment 1
- Underestimating psychological impact: Hair loss causes significant emotional distress; spend time explaining the condition and prognosis 1, 5
- Premature biopsy: Only perform if diagnosis is genuinely uncertain after clinical examination 3, 1
Immediate Next Steps
Perform a focused scalp examination looking for the specific features above, particularly exclamation mark hairs and pattern of loss. If typical alopecia areata patches are present with characteristic findings, no laboratory testing is needed. Provide detailed counseling about the high likelihood of spontaneous recovery (68% if <25% involvement) and arrange dermatology follow-up for treatment discussion if patches are extensive or psychologically distressing 1.